These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27187277)

  • 1. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.
    Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC
    Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of αvβ3 integrin and core-linked CD44.
    Kim SI; Kim YH; Kang BG; Kang MK; Lee EJ; Kim DY; Oh H; Oh SY; Na W; Lim SS; Kang YH
    Phytomedicine; 2020 Dec; 79():153351. PubMed ID: 32987362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis.
    Zhang B; Dai J; Wang H; Wei H; Zhao J; Guo Y; Fan K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):795-800. PubMed ID: 25201732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.
    Kim H; Choi HK; Shin JH; Kim KH; Huh JY; Lee SA; Ko CY; Kim HS; Shin HI; Lee HJ; Jeong D; Kim N; Choi Y; Lee SY
    J Clin Invest; 2009 Apr; 119(4):813-25. PubMed ID: 19258703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.
    Lee EJ; Kim JL; Gong JH; Park SH; Kang YH
    Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy.
    Zur Y; Rosenfeld L; Keshelman CA; Dalal N; Guterman-Ram G; Orenbuch A; Einav Y; Levaot N; Papo N
    PLoS Biol; 2018 Aug; 16(8):e2002979. PubMed ID: 30142160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization.
    Jiang M; Peng L; Yang K; Wang T; Yan X; Jiang T; Xu J; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Deng L; Yang C
    J Med Chem; 2019 Jun; 62(11):5370-5381. PubMed ID: 31082234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.
    Izawa T; Zou W; Chappel JC; Ashley JW; Feng X; Teitelbaum SL
    Mol Cell Biol; 2012 Jul; 32(14):2943-53. PubMed ID: 22615494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway.
    Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY
    J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2.
    Kwon JO; Jin WJ; Kim B; Kim HH; Lee ZH
    Eur J Pharmacol; 2015 Dec; 768():189-98. PubMed ID: 26528796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
    Rao H; Lu G; Kajiya H; Garcia-Palacios V; Kurihara N; Anderson J; Patrene K; Sheppard D; Blair HC; Windle JJ; Choi SJ; Roodman GD
    J Bone Miner Res; 2006 Oct; 21(10):1657-65. PubMed ID: 16995821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitory effect of Foeniculum vulgare Miller extract on osteoclast differentiation and ovariectomy-induced bone loss.
    Kim TH; Kim HJ; Lee SH; Kim SY
    Int J Mol Med; 2012 Jun; 29(6):1053-9. PubMed ID: 22447109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation.
    Min SK; Kang HK; Jung SY; Jang DH; Min BM
    Cell Death Differ; 2018 Feb; 25(2):268-281. PubMed ID: 28937683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.